From: Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
Grade
Toxicity
1
2
3
4
Gastrointestinal
6
0
Hematological
Thrombocytopenia
Neutropenia
Anemia
Infection